Turn Therapeutics Inc. Common Stock (TTRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Turn Therapeutics Inc. Common Stock (TTRX) has a cash flow conversion efficiency ratio of -0.267x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.63 Million) by net assets ($6.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TTRX net asset value for net asset value and shareholders' equity analysis.
Turn Therapeutics Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Turn Therapeutics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Turn Therapeutics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Turn Therapeutics Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SKY Metals Ltd
AU:SKY
|
-0.040x |
|
DAEA TI Co. Ltd
KQ:045390
|
-0.059x |
|
Surya Fajar Capital Tbk PT
JK:SFAN
|
-0.027x |
|
Hsing Ta Cement Co Ltd
TW:1109
|
0.042x |
|
Ordinary Fully Paid Deferred Settlement
AU:BTRDA
|
N/A |
|
Intellego Technologies AB
ST:INT
|
0.791x |
|
Shanghai Longyun Advg & Media
SHG:603729
|
0.031x |
|
Bikurey Hasade Holdings Ltd
TA:BKRY
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Turn Therapeutics Inc. Common Stock from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Turn Therapeutics Inc. Common Stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.69 Million | $-2.56 Million | -0.547x | -107.13% |
| 2024-12-31 | $-177.43K | $-1.36 Million | 7.672x | +147.76% |
| 2023-12-31 | $85.77K | $-1.38 Million | -16.063x | -- |
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and de… Read more